These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 741271)

  • 1. [Estramustine phosphate in the treatment of stage D prostatic carcinoma].
    van Wyk J
    S Afr Med J; 1978 Oct; 54(16):638. PubMed ID: 741271
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of advanced carcinoma of the prostate with estramustine phosphate (estracyt)].
    Lancina Martín JA; Chantada Abal V; Lamas Meilan AC; González Martín M
    Actas Urol Esp; 1984; 8(5):399-402. PubMed ID: 6524487
    [No Abstract]   [Full Text] [Related]  

  • 3. Disappearance of osteoblastic metastases in prostatic carcinoma following estramustine therapy.
    Catane R; Kaufman J; Mittelman A; Murphy GP
    JAMA; 1977 Jun; 237(23):2471. PubMed ID: 576957
    [No Abstract]   [Full Text] [Related]  

  • 4. Estramustine phosphate versus stilbestrol as primary treatment for metastatic cancer of the prostate.
    Nickel CJ; Morales A
    Can J Surg; 1983 Sep; 26(5):434-8. PubMed ID: 6351988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer of the prostate. Treating metastasis with estramustine phosphate.
    Hoeft RT; Jones AG
    Am J Nurs; 1982 May; 82(5):829-30. PubMed ID: 6918193
    [No Abstract]   [Full Text] [Related]  

  • 6. Estramustine phosphate therapy in poorly differentiated carcinoma of the prostate.
    Edsmyr F; Esposti PL; Andersson L
    Scand J Urol Nephrol Suppl; 1980; 55():139-42. PubMed ID: 6938017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of prostatic carcinoma with estramustine phosphate (Estracyt).
    Benson RC
    Wis Med J; 1976 Sep; 75(9):S89-90. PubMed ID: 969557
    [No Abstract]   [Full Text] [Related]  

  • 8. [Total remission of prostatic cancer following treatment with Estracyt].
    Romics I
    Orv Hetil; 1982 Jan; 123(5):287-9. PubMed ID: 7063244
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of estramustine phosphate and streptozotocin in patients with advanced prostatic carcinoma who have had extensive irradiation.
    Murphy GP; Gibbons RP; Johnson DE; Loening SA; Prout GR; Schmidt JD; Bross DS; Chu TM; Gaeta JF; Saroff J; Scott WW
    J Urol; 1977 Aug; 118(2):288-91. PubMed ID: 142845
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of advanced oestrogen-resistant prostatic carcinoma with estramustine phosphate.
    Wong AL; McGeorge A; Abel BJ
    Clin Oncol; 1981 Jun; 7(2):163-5. PubMed ID: 7249439
    [No Abstract]   [Full Text] [Related]  

  • 11. Primary treatment of prostatic carcinoma with estramustine phosphate: preliminary report.
    Nilsson T; Jonsson G
    J Urol; 1976 Feb; 115(2):168-9. PubMed ID: 1249870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experiences with estramustine phosphate (Estracyt, Emcyt) in prostate cancer.
    Murphy GP; Slack NH; Mittelman A
    Semin Oncol; 1983 Sep; 10(3 Suppl 3):34-42. PubMed ID: 6364365
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of advanced carcinoma of the prostate with Estracyt.
    Nagel R; Kölln CP
    Prog Clin Biol Res; 1976; 6():267-84. PubMed ID: 1023214
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral estramustine phosphate. Prolonged therapy for advanced carcinoma of prostate.
    Catane R; Mittelman A; Kaufman J; Murphy GP
    N Y State J Med; 1976 Nov; 76(12):1978-81. PubMed ID: 1069190
    [No Abstract]   [Full Text] [Related]  

  • 15. New steroidal alkylating agents in advanced stage D carcinoma of the prostate.
    Mittelman A; Catane R; Murphy GP
    Cancer Treat Rep; 1977; 61(2):307-10. PubMed ID: 872134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Estracyt treatment in prostatic neoplasms].
    Sander S
    Tidsskr Nor Laegeforen; 1976 Jan; 96(1):27-8. PubMed ID: 1257949
    [No Abstract]   [Full Text] [Related]  

  • 17. [Predictive value of clinical, biochemical, hormonal and histologic parameters of the endocrine response in prostatic adenocarcinoma].
    Burgos FJ; Maganto E; Jiménez M; Mayayo T; Allona A; Mateos A; Escudero A; Romero-Aguirre C
    Actas Urol Esp; 1988; 12(6):500-6. PubMed ID: 3232555
    [No Abstract]   [Full Text] [Related]  

  • 18. Estramustine phosphate vs diethylstilbestrol in the treatment of stage D prostate cancer.
    Benson RC; Cummings K
    Prog Clin Biol Res; 1989; 303():177-86. PubMed ID: 2674984
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical results with estramustine phosphate (NSC-89199): a comparison of the intravenous and oral preparations.
    Nilsson T; JONSSON G
    Cancer Chemother Rep; 1975; 59(1):229-32. PubMed ID: 1093671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of estramustine phosphate in the treatment of estrogen-resistant prostatic adenocarcinoma].
    Toulouse J; Jung JL; Bittard M
    J Urol (Paris); 1984; 90(1):27-33. PubMed ID: 6725973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.